1. Home
  2. PTIX vs NBY Comparison

PTIX vs NBY Comparison

Compare PTIX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • NBY
  • Stock Information
  • Founded
  • PTIX 1994
  • NBY 2000
  • Country
  • PTIX United States
  • NBY United States
  • Employees
  • PTIX N/A
  • NBY N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • PTIX Health Care
  • NBY
  • Exchange
  • PTIX Nasdaq
  • NBY Nasdaq
  • Market Cap
  • PTIX 6.3M
  • NBY 6.3M
  • IPO Year
  • PTIX 2016
  • NBY 2007
  • Fundamental
  • Price
  • PTIX $2.05
  • NBY $1.08
  • Analyst Decision
  • PTIX
  • NBY
  • Analyst Count
  • PTIX 0
  • NBY 0
  • Target Price
  • PTIX N/A
  • NBY N/A
  • AVG Volume (30 Days)
  • PTIX 71.8K
  • NBY 147.5K
  • Earning Date
  • PTIX 11-28-2025
  • NBY 11-07-2025
  • Dividend Yield
  • PTIX N/A
  • NBY N/A
  • EPS Growth
  • PTIX N/A
  • NBY N/A
  • EPS
  • PTIX N/A
  • NBY 0.47
  • Revenue
  • PTIX N/A
  • NBY $10,302,000.00
  • Revenue This Year
  • PTIX N/A
  • NBY $23.91
  • Revenue Next Year
  • PTIX N/A
  • NBY $32.05
  • P/E Ratio
  • PTIX N/A
  • NBY $41.58
  • Revenue Growth
  • PTIX N/A
  • NBY 390.34
  • 52 Week Low
  • PTIX $1.83
  • NBY $0.46
  • 52 Week High
  • PTIX $14.28
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 41.67
  • NBY 44.62
  • Support Level
  • PTIX $1.83
  • NBY $1.00
  • Resistance Level
  • PTIX $2.11
  • NBY $1.11
  • Average True Range (ATR)
  • PTIX 0.18
  • NBY 0.07
  • MACD
  • PTIX 0.02
  • NBY 0.01
  • Stochastic Oscillator
  • PTIX 49.13
  • NBY 42.53

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: